3 results
Approved WMOCompleted
Primary:The primary objective of Study 218MS305 is to determine whether prolonged-release fampridine (10 mg BID) has a clinically meaningful effect on patient-reported walking ability over a 24-week study period.Secondary:The secondary objectives…
Approved WMORecruiting
The assess the safety and efficacy of prostate artery embolization (PAE) with polyethylene glycol microspheres (PEGM) in patients with low urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH).
Approved WMORecruiting
To determine the minimum number of CESB-guided tissue samples needed to establish a final histopathological biopsy diagnosis for ROLs.